US Patent 9597397 Formulations of bendamustine
Patent 9597397 was granted and assigned to Eagle Pharmaceuticals, Inc. on March, 2017 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9597397 Formulations of bendamustine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.